Department of Medicine
Faculty Profiles by Division

Department of Medicine

Faculty Profiles

[Return To Index page]
photo Anson Conrad Smith, MD


Associate Professor of Medicine

Associate Chief of Cardiology for Diversity, Equity, and Inclusion

Director Cardiac Catheterization Labs


Phone: 412-647-0211

Office: Heart and Vascular Institute, UPMC Presbyterian
200 Lothrop Street
Pittsburgh, PA 15213
Phone: 412-647-0211
Fax: 412-648-6101
Education and Training
BS, Stanford University, 1983
MD, University of California, San Francisco Sch Med, 1987
MMM, Carnegie Mellon University, 2011
Intern in Medicine, Massachusetts General Hospital, Harvard Med Sch, 1987
Resident in Medicine, Massachusetts General Hospital, Harvard Med Sch, 1988
Clinical Fellow in Cardiology, Massachusetts General Hospital, Harvard Med Sch, 1990
Clin & Research Interven Fellow Cardiol, Massachusetts General Hospital, Harvard Med Sch, 1992
Research Interest
Dr. Smith's research interests are primarily in the area of analysis of outcomes after percutaneous coronary intervention. As the Director of the Cardiac Catheterization Laboratory, he is overseeing the development of our cath lab database system which will provide a wealth of research potential to evaluate various aspects in interventional cardiology. He has worked with Dr. Dennis McNamara in developing a database of coronary intervention patients in which we are currently evaluating the potential genetic basis of cardiac disease. Dr. Smith also serves as the Governor of the Western Pennsylvania Chapter of the American College of Cardiology where he has the unique opportunity to directly impact the practice of cardiology in this region.
Clinical Interest
Dr. Conrad Smith is the Director of Cardiac Catheterization Laboratory at Presbyterian Hospital of UPMC. His clinical interests are in the areas or interventional cardiology where he has a very active practice in coronary intervention. He also has extensive experience in the treatment of mitral valve stenosis with mitral valvuloplasty, an alternative to surgical therapy for mitral valve disease in selected patients. With his extensive clinical experience, Dr. Smith travels internationally to share his perspectives on the practice of interventional cardiology.
For my complete bibliography, Click Here.
Selected Publications:
Olafiranye O, Vlachos HA, Mulukutla SR, Marroquin OC, Selzer F, Kelsey SF, Williams DO, Strollo PJ, Reis SE, Jee JS, Smith AJ. Comparison of long-term safety and efficacy outcomes after drug-eluting and bare-metal stent use across racial groups: Insights from NHLBI Dynamic Registry. Olafiranye O, Vlachos H, Mulukutla SR, Marroquin OC, Selzer F, Kelsey SF, Williams DO, Strollo PJ, Reis SE, Lee JS, Smith AJ. Int J Cardiol. 2015; 184: 79-85.
Chu D, Anastacio MM, Mulukutla SR, Lee JS, Smith AJ, Marroquin OC, Sanchez CE, Morell VO, Cook CC, Lico SC, Wei LM, Badhwar V. Safety and efficacy of implementing a multidisciplinary heart team approach for revascularization in patients with complex coronary artery disease: an observational cohort pilot study. JAMA Surg. 2014; 149(11): 1109-12.
Badhwar V, Smith AJ, Cavalcante JL. A pathoanatomic approach to the management of mitral regurgitation. Trends Cardiovasc Med. 2016; 26(2): 126-34.
Sanchez CE, Badhwar V, Dota A, Schindler J, Chu D, Smith AJ, Lee JS, Khandhar S, Toma C, Marroquin OC, Schmidhofer M, Bhama J, Wei L, Scolieri S, Esper S, Lee A, Mulukutla SR. Practical implementation of the coronary revascularization heart team. Circ Cardiovasc Qual Outcomes. 2013; 6(5): 598-603.
Mulukutla SR, Marroquin OC, Vlachos HA, Selzer F, Toma C, Kip KE, Abbott JD, Holper E, Lee JS, Khandhar S, Kutcher M, Kelsey S, Smith Cq Faxon D, Williams DO. Benefit of long-term dual anti-platelet therapy in patients treated with drug-eluting stents: from the NHLBI dynamic registry. Am J Cardiol. 2013; 111(4): 486-92.